Monday, February 13, 2012

New Medication May Aid Late-Stage Prostate Patients

(Medical News Today) UPDATED 2010-02-24
A Phase 3 trail on the drug abiraterone has found it may benefit patients with late-stage prostate cancer. The study of 47 men who had undergone hormone therapy and docetaxel found that about three quarters of those who took abiraterone experienced a drop in PSA levels. Half of the men in the trail experienced a drop of at least 50 percent, and five of the 47 patients in the trial were reported to still be taking the drug three years after the study started.
  Read full story >
See all Prostate News

People who read this also read...

  • Prostate Cancer Stages
  • Prostate Cancer Stage 3
  • Late Stage Prostate Cancer Psa Level
  • What Happens In The Late Stages Of Diabetes?
  • Late Stage Hiv Symptoms
  • Hypoglycemia Prostatitis